Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

2.25
Delayed Data
As of Mar 24
 -0.04 / -1.75%
Today’s Change
1.10
Today|||52-Week Range
15.40
+73.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.5M9.3M4.8M5.8M
 
 
 
 
 
Cost of Goods Sold2.6M748.0K622.0K3.6M
 
 
 
 
 
Depreciation And Amortization77.0K170.0K300.0K289.0K
 
 
 
 
 
 
Operating ExpensesGross Income-120.0K8.3M3.9M1.9M
 
 
 
 
 
General Expenses18.7M32.7M25.2M15.3M
 
 
 
 
 
Research And Development5.1M21.3M14.6M6.8M
 
 
 
 
 
Total Operating Expenses21.3M33.6M26.1M19.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.8M-24.4M-21.2M-13.4M
 
 
 
 
 
Extraordinary Credit534.0K1.8M3.2M6.8M
 
 
 
 
 
Extraordinary Charge---82.0K0.000.00
 
 
Interest Expense On Debt727.0K339.0K845.0K783.0K
 
 
 
 
 
Other Expenses3.1M553.0K-166.0K-36.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.9M-22.5M-19.0M-7.4M
 
 
 
 
 
Discontinued Operations135.0K691.0K0.000.00
 
 
 
Extraordinary Items-1.2M0.000.000.00
 
 
Net Income-15.7M-21.8M-19.0M-7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.4M4.0M5.0M6.5M
 
 
 
 
 
Shares To Calculate EPS Diluted3.4M4.0M5.0M6.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.90-$5.50-$3.80-$1.14
 
 
 
 
 
EPS Diluted-$4.57-$5.50-$3.83-$1.14